GLPwatch
Trials (2139)
Page 13 of 36.
- A Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes Who Observe Ramadan Fasting
- SCALE KIDS: Research Study to Look at How Well a New Medicine is at Lowering Weight in Children With Obesity
- A Study of Orforglipron in Adult Participants With Obesity or Overweight and Type 2 Diabetes
- Impact of Semaglutide Withdrawal on Cardiometabolic Profile and Physiology of Energy Balance: Recovery Effects After Semaglutide Termination
- A Research Study to Compare Two Different Forms of Once-weekly Semaglutide in Two Different Injection Pens
- Effects of GLP-1 on Chronic Heart Failure
- Evaluation of Lixisenatide Efficacy in Diabetes Mellitus Type 2 With Failure of Other GLP-1 Analog
- Feasibility of Once/Daily Administered GLP/1 Receptoragonist (Lixisenatide) in Combination With Basal Insulin
- Glucagon-like Peptide 1 Receptor Agonist in Acute Large Vessel Occlusion Stroke Treated by Reperfusion Therapies
- Impact of Neuropathy on the Risk of Semaglutide-Induced Gastric Retention
- Regulatory Post Marketing Surveillance (rPMS) Study of Xultophy® (Insulin Degludec/Liraglutide) to Evaluate Safety and Effectiveness in Patients With Type 2 Diabetes Mellitus in Routine Clinical Practice in Korea
- A Research Study to See How Well CagriSema Helps People With Excess Body Weight Lose Weight
- A Research Study Looking at New Protein-based Tablets in Healthy Men - Oral Formulation III
- Exenatide Inpatient Trial: A Randomized Controlled Pilot Trial on the Safety and Efficacy of Exenatide (Byetta®) Therapy for the Inpatient Management of Patients With Type 2 Diabetes
- Observational Study on Efficacy and Safety of Liraglutide in Subjects With Type 2 Diabetes
- The Effects of Glucose Control and Weight Loss Between Beinaglutide and Dulaglutide in Type 2 Diabetes With Overweight or Obesity.
- Rebalancing the Fat Content of the Heart and Muscles
- Investigation on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of NN9924 in Healthy Male Subjects
- Comparative Effectiveness of Tirzepatide vs Semaglutide in Participants With Type 2 Diabetes and Heart Failure With Preserved Ejection Fraction
- A Study of LY3532226 in Participants With Type 2 Diabetes Mellitus
- A Study of the Effect of LY2189265 on Two Blood Pressure Drugs
- Cognitive Dysfunction and Glucagon-like Peptide-1 Agonists
- The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)
- Research on Timing of Liraglutide Therapy in Patients With Obesity After Metabolic Surgery
- A Study to Evaluate ITCA 650 Compared to Glimepiride as Add on Therapy for the Treatment of Type 2 Diabetes
- Weight Loss in People Living With Overweight or Obesity and Type 2 Diabetes Following Treatment With Cagrilintide
- A Study of LY3305677 in Participants With Obesity Or Overweight
- Comparison of the Effect of Liraglutide in Young Versus Elderly Healthy Volunteers
- A Study of Tirzepatide Administered by Two Different Devices in Healthy Participants
- A Long-term Trial to Compare the Effects of Liraglutide and Sulphonylurea (Glimepiride) Both in Combination With Metformin on Clinical, Endothelial and Image Markers of Cardiovascular Risk in Patients With Type 2 Diabetes
- Efficacy and Safety of Semaglutide Injection vs Ozempic® in Patients With Type 2 Diabetes
- Pre-approval Expanded Access of Retatrutide (LY3437943)
- Role of Semaglutide in Restoring Ovulation in Youth and Adults With Polycystic Ovary Syndrome
- Screening and Intervention for Subclinical Coronary Artery Disease in Patients With Type 2 Diabetes
- Effects of a GLP-1 Receptor Agonist on Functional Activation and Connectivity of the Brain
- Exploratory Study to Investigate the Effect of Dapagliflozin and Exenatide Combined on Body Weight
- A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Switzerland, as Part of Local Clinical Practice
- A Study to Evaluate Cardiovascular Outcomes in Patients With Type 2 Diabetes Treated With ITCA 650
- The Effect of Liraglutide Compared to Sitagliptin, Both in Combination With Metformin on Glycaemic Control in Subjects With Type 2 Diabetes Mellitus
- The Effects of Physical Training and GLP-1 Receptor Agonist Liraglutide Treatment in Patients With Type 2 Diabetes
- Safety and Efficacy of Exenatide Once Weekly Versus Liraglutide in Subjects With Type 2 Diabetes
- Semaglutide's Effect on Renal Hemodynamics and Function in Patients With Type 2 Diabetes Mellitus and Nephropathy
- Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination Versus Insulin Glargine in Patients With Type 2 Diabetes (LixiLan-India)
- Exenatide For Reducing the Reinforcing Effects of Cocaine
- A Research Study Comparing How Well Different Doses of the Medicine NN0519-0130 Help People With Excess Body Weight Lose Weight
- "Efficacy of Once Weekly GLP 1 Analogue: Semaglutide. A Multicenter Experience From Pakistan."
- Combination of Biologic and Anti-obesity Therapies in Psoriatic Arthritis
- POSE2.0 With GLP-1 Agonist for Obesity Management
- Metabolic Defects in Prediabetic Kuwaiti Arabs and Indians
- Mazdutide for Adults With Prediabetes: A Randomized, Double-Blind, Placebo-Controlled Trial (DREAM-PRE)
- Effects of LY2189265 on Glycemic Control in Participants With Type 2 Diabetes
- GLP-1s to Enhance Lasting Optimal Weight
- A Study of LY3437943 in Chinese Participants With Obesity Or Overweight
- Novel Therapeutics and Endothelial Dysfunction in T1DM Patients
- PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes
- A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes
- Plasma Glucagon-like Peptide-1 Levels and In-hospital Complications in ST-segment Elevation Myocardial Infarction
- A Study of HS-20094 in Patients With T2DM
- Effects of Incretin on the Blood Pressure and Lipid in Patients With Overweight or Obese Diabetes
- Safety Evaluation of Adverse Reactions in Diabetes